U.S. federal trademark · Serial No. 78079597
liposome encapsulated pharmaceutical preparations delivered via the pulmonary system for the treatment of cancer, auto-immune disorders, metabolic disorders, rheumatic disorders, heart disease, lung disease, diseases affecting the central nervous system, viral and bacterial infections, and post-surgical and cancer-related pain
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.